New approaches for biomonitoring exposure to the human carcinogen aristolochic acid

Bioactivation of the human carcinogen aristolochic acid

(2014) Viktoriya S. Sidorenko et al.   CARCINOGENESIS

Formalin-fixed paraffin-embedded tissue as a source for quantitation of carcinogen DNA adducts: aristolochic acid as a prototype carcinogen

(2014) Byeong Hwa Yun et al.   CARCINOGENESIS

Quantification of aristolochic acids I and II in herbal dietary supplements by ultra-high-performance liquid chromatography–multistage fragmentation mass spectrometry

(2014) Lukas Vaclavik et al.   Food Additives and Contaminants Part A-Chemistry Analysis Control Exposure & Risk Assessment

Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid

(2014) Bojan Jelaković et al.   INTERNATIONAL JOURNAL OF CANCER

Unambiguous Detection of Multiple TP53 Gene Mutations in AAN-Associated Urothelial Cancer in Belgium Using Laser Capture Microdissection

(2014) Selda Aydin et al.   PLoS One

Variation in genomic landscape of clear cell renal cell carcinoma across Europe

(2014) Ghislaine Scelo et al.   Nature Communications

Mutational landscape of intrahepatic cholangiocarcinoma

(2014) Shanshan Zou et al.   Nature Communications

Human Formalin-Fixed Paraffin-Embedded Tissues: An Untapped Specimen for Biomonitoring of Carcinogen DNA Adducts by Mass Spectrometry

(2013) Byeong Hwa Yun et al.   ANALYTICAL CHEMISTRY

The Epidemiology, Diagnosis, and Management of Aristolochic Acid Nephropathy

(2013) M. Refik Gökmen et al.   ANNALS OF INTERNAL MEDICINE

Risk Assessment of Upper Tract Urothelial Carcinoma Related to Aristolochic Acid

(2013) F. Wu et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy

(2013) Heinz H. Schmeiser et al.   INTERNATIONAL JOURNAL OF CANCER

Genome-Wide Mutational Signatures of Aristolochic Acid and Its Application as a Screening Tool

(2013) S. L. Poon et al.   Science Translational Medicine

Mutational Signature of Aristolochic Acid Exposure as Revealed by Whole-Exome Sequencing

(2013) M. L. Hoang et al.   Science Translational Medicine

On the origins and development of the 32P-postlabelling assay for carcinogen–DNA adducts

(2012) David H. Phillips   CANCER LETTERS

The analysis of DNA adducts: The transition from 32P-postlabeling to mass spectrometry

(2012) Joshua J. Klaene et al.   CANCER LETTERS

Biomonitoring of Aristolactam-DNA Adducts in Human Tissues Using Ultra-Performance Liquid Chromatography/Ion-Trap Mass Spectrometry

(2012) Byeong Hwa Yun et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Quantitation of DNA Adducts by Stable Isotope Dilution Mass Spectrometry

(2012) Natalia Tretyakova et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease

(2012) Arthur P. Grollman   ENVIRONMENTAL AND MOLECULAR MUTAGENESIS

Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy

(2012) Marc E. De Broe   KIDNEY INTERNATIONAL

Aristolochic acid-associated urothelial cancer in Taiwan

(2012) C.-H. Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Ultraperformance Liquid Chromatography−Tandem Mass Spectrometry Method for Biomonitoring Cooked Meat Carcinogens and Their Metabolites in Human Urine

(2011) Dan Gu et al.   ANALYTICAL CHEMISTRY

Metabolism and Biomarkers of Heterocyclic Aromatic Amines in Molecular Epidemiology Studies: Lessons Learned from Aromatic Amines

(2011) Robert J. Turesky et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Nucleic acid quantity and quality from paraffin blocks: Defining optimal fixation, processing and DNA/RNA extraction techniques

(2011) Gulisa Turashvili et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

TP53 Mutational signature for aristolochic acid: an environmental carcinogen

(2011) Masaaki Moriya et al.   INTERNATIONAL JOURNAL OF CANCER

Physiological and Molecular Characterization of Aristolochic Acid Transport by the Kidney

(2011) K. G. Dickman et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid

(2011) Bojan Jelaković et al.   KIDNEY INTERNATIONAL

Lack of recognition by global-genome nucleotide excision repair accounts for the high mutagenicity and persistence of aristolactam-DNA adducts

(2011) Victoria S. Sidorenko et al.   NUCLEIC ACIDS RESEARCH

Bioactivation versus Detoxication of the Urothelial Carcinogen Aristolochic Acid I by Human Cytochrome P450 1A1 and 1A2

(2011) Marie Stiborová et al.   TOXICOLOGICAL SCIENCES

Risks of Kidney Failure Associated With Consumption of Herbal Products Containing Mu Tong or Fangchi: A Population-Based Case-Control Study

(2010) Ming-Nan Lai et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Formation of Deoxyguanosine Cross-Links from Calf Thymus DNA Treated with Acrolein and 4-Hydroxy-2-nonenal

(2010) Ivan D. Kozekov et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Identification of Carcinogen DNA Adducts in Human Saliva by Linear Quadrupole Ion Trap/Multistage Tandem Mass Spectrometry

(2010) Erin E. Bessette et al.   CHEMICAL RESEARCH IN TOXICOLOGY

A novel and specific method for the determination of aristolochic acid-derived DNA adducts in exfoliated urothelial cells by using ultra performance liquid chromatography–triple quadrupole mass spectrometry

(2010) Lin Guo et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Dual-Pressure Linear Ion Trap Mass Spectrometer Improving the Analysis of Complex Protein Mixtures

(2009) Tonya Pekar Second et al.   ANALYTICAL CHEMISTRY

Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization

(2009) Annie M. Jarabek et al.   CRITICAL REVIEWS IN TOXICOLOGY

Creating context for the use of DNA adduct data in cancer risk assessment: II. Overview of methods of identification and quantitation of DNA damage

(2009) Matthew W. Himmelstein et al.   CRITICAL REVIEWS IN TOXICOLOGY

Population-Based Case-Control Study of Chinese Herbal Products Containing Aristolochic Acid and Urinary Tract Cancer Risk

(2009) M.-N. Lai et al.   JNCI-Journal of the National Cancer Institute

DNA adducts of aristolochic acid II: total synthesis and site-specific mutagenesis studies in mammalian cells

(2009) Sivaprasad Attaluri et al.   NUCLEIC ACIDS RESEARCH

Polycyclic Aromatic Hydrocarbon Exposure, Urinary Mutagenicity, and DNA Adducts in Rubber Manufacturing Workers

(2008) S. Peters et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Advances in Chemical Carcinogenesis: A Historical Review and Prospective

(2008) L. A. Loeb et al.   CANCER RESEARCH

Aristolochic acid nephropathy: A worldwide problem

(2008) Frédéric D. Debelle et al.   KIDNEY INTERNATIONAL

Mining the archival formalin-fixed paraffin-embedded tissue proteome: opportunities and challenges

(2008) Niroshini J. Nirmalan et al.   Molecular BioSystems

Quantification of aristolochic acid-derived DNA adducts in rat kidney and liver by using liquid chromatography–electrospray ionization mass spectrometry

(2008) Wan Chan et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy

(2007) Marie Stiborová et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH